{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:35:23Z","timestamp":1649126123037},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T00:00:00Z","timestamp":1607817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,29]]},"DOI":"10.1093\/jalm\/jfaa184","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T19:57:33Z","timestamp":1601409453000},"page":"784-789","source":"Crossref","is-referenced-by-count":0,"title":["No Longer Benign: Altered Mental Status and Apparent Coagulopathy in a Woman with Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.1093","volume":"6","author":[{"given":"Meredith G","family":"Parsons","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy S","family":"Halvorson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra L","family":"Isaacson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L","family":"Blau","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E","family":"Merrill","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,13]]},"reference":[{"key":"2021043007580755300_jfaa184-B1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"2021043007580755300_jfaa184-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-40320-5_1","article-title":"Mgus and smoldering multiple myeloma: diagnosis and epidemiology","volume":"169","author":"Mateos","year":"2016","journal-title":"Cancer Treat Res"},{"key":"2021043007580755300_jfaa184-B3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2018-06-846816","article-title":"Acute hyperviscosity: syndromes and management","volume":"132","author":"Gertz","year":"2018","journal-title":"Blood"},{"key":"2021043007580755300_jfaa184-B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"2021043007580755300_jfaa184-B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"2021043007580755300_jfaa184-B6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"key":"2021043007580755300_jfaa184-B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2008.07577.x","article-title":"Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias","volume":"145","author":"Eby","year":"2009","journal-title":"Br J Haematol"},{"key":"2021043007580755300_jfaa184-B8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/asheducation-2007.1.158","article-title":"Bleeding and thrombosis risks in plasma cell dyscrasias","volume":"2007","author":"Eby","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2021043007580755300_jfaa184-B9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.transci.2012.06.021","article-title":"A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange","volume":"48","author":"Post","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"2021043007580755300_jfaa184-B10","doi-asserted-by":"crossref","first-page":"e229312","DOI":"10.1136\/bcr-2019-229312","article-title":"Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma","volume":"12","author":"Siddiq","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2021043007580755300_jfaa184-B11","first-page":"602","article-title":"Diagnosis and management of dysfibrinogenemia","volume":"16","author":"Shapiro","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"2021043007580755300_jfaa184-B12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5858\/2002-126-0499-LDOD","article-title":"Laboratory diagnosis of dysfibrinogenemia","volume":"126","author":"Cunningham","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"2021043007580755300_jfaa184-B13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.11613\/BM.2016.028","article-title":"Interference of m-protein on prothrombin time test\u2014case report","volume":"26","author":"Margetic","year":"2016","journal-title":"Biochem Med"},{"key":"2021043007580755300_jfaa184-B14","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1055\/s-0039-1683969","article-title":"Interference of monoclonal gammopathy with fibrinogen assay producing spurious dysfibrinogenemia","volume":"03","author":"Martini","year":"2019","journal-title":"TH Open"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/3\/784\/37598631\/jfaa184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/3\/784\/37598631\/jfaa184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T08:02:11Z","timestamp":1619769731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/6\/3\/784\/6032302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,13]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,12,13]]},"published-print":{"date-parts":[[2021,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaa184","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,12,13]]}}}